Overall rank by patents
#19,868
Across all tracked assignees
USPTO PatentsView assignee record - 14 granted patents across 12 technology areas, active 2015–2018. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: B21J (FORGING; HAMMERING; PRESSING METAL; RIVETING; FORGE FURNACES).
The verdict
Henrob holds 14 US patents across 12 technology areas, rank #19,868 of 50,000 tracked assignees.
Henrob Limited has been granted 14 US utility patents between 2015 and 2018, placing Henrob Limited at rank #19,868 across all assignees tracked by PlainPatent. This portfolio spans 12 distinct Cooperative Patent Classification (CPC) subclasses, averaging 24.7 claims per patent with primary concentration in B21J (FORGING; HAMMERING; PRESSING METAL; RIVETING; FORGE FURNACES). As a Foreign Corporation, Henrob Limited is one of the more focused assignees in the PatentsView dataset. By volume, Henrob sits between Heartbeam, Inc. (14 patents, rank #19,864) and Hong Kong R&D Centre For Logistics And Supply Chain Management Enabling Technologies Limited (14 patents, rank #19,872) - the closest US assignees by grant volume. The composite Innovation Score of 36.4/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 0 grants, compared with 14 in the 2015–2019 window, a -100% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Henrob Limited's 24.7 average claims per patent reflects complex, broadly scoped inventions that are difficult for competitors to design around, while concentration in 12 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Henrob Limited against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
HeartBeam, Inc.
14 patents
Hefei BOE Vision-Electronic Technology Co., Ltd.
14 patents
Helmholtz-Zentrum hereon GmbH
14 patents
Hemex Health, Inc.
14 patents
Hi. Q, Inc.
14 patents
High Power Opto, Inc.
14 patents
Holovisions LLC
14 patents
Hong Kong R&D Centre for Logistics and Supply Chain Management Enabling Technologies Limited
14 patents
Henrob Limited
14 patents
What this shows Henrob holds 14 patents at rank #19,868, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #19,868 in granted patent volume.
Other assignees with the most granted patents in Henrob's primary technology class.
Henrob's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
36 Top 46% higher than 54% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 2 | 14.3% |
| 2016 | 6 | 42.9% |
| 2017 | 2 | 14.3% |
| 2018 | 4 | 28.6% |
Top 12 of 12 technology areas
Overall rank by patents
#19,868
Across all tracked assignees
36.4 out of 100
How to use this portfolio
Henrob's 14 grants land it in the top 46% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.